2025 Annual Meeting | C35 - A Clinical Approach to Undifferentiated Gait Disorders
Program Materials Program Evaluations
02:30 PM - 02:35 PM PDT | Introduction |
Introduction
Meabh O'Hare, MD |
02:35 PM - 03:00 PM PDT | Speaker |
An Approach to Gait Analysis - Insights from Neurologic Physical Therapy and Rehabilitation
Kathleen Taglieri-Noble, PT |
03:00 PM - 03:35 PM PDT | Speaker |
Introduction to Gait Disorders Seen by Neuromuscular Neurology
Meabh O'Hare, MD |
03:35 PM - 04:10 PM PDT | Speaker |
Introduction to Gait Disorders Seen by Movement Neurology
Xenos Mason, MD |
04:10 PM - 04:30 PM PDT | Q&A |
Audience Participation – Case-Based Gait Analysis
Meabh O'Hare, MD, Xenos Mason, MD |
Meabh O'Hare, MD | Dr. O'Hare has nothing to disclose. |
Xenos Mason, MD | Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott Labs. Dr. Mason has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen . Dr. Mason has received research support from The SC-CSTI. |
Kathleen Taglieri-Noble, PT | Dr. Taglieri-Noble has nothing to disclose. |